sábado, 10 de enero de 2026
Responding to declining global fertility rates The Lancet +++ +...
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00034-6/fulltext?dgcid=raven_jbs_etoc_email
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01962-2/abstract?dgcid=raven_jbs_etoc_feature_lancet
Tafasitamab, lenalidomide, and rituximab in relapsed or refractory follicular lymphoma (inMIND): a global, phase 3, randomised controlled trial
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01778-7/abstract?dgcid=raven_jbs_etoc_feature_lancet
Jan 10, 2026
Volume 407Number 10524p105-194
https://www.thelancet.com/journals/lancet/issue/vol407no10524/PIIS0140-6736(26)X0002-2
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario